Woman and Man | Between 18 years et 70 years
- | Country :
- France
- | organs :
- Leucémies aiguës
- | Specialty :
- Thérapies Ciblées
Extract
Phase 2 study of Ponatinib (Iclusig) for prevention of relapse after allogeneic stem cell transplantation (allo-SCT) in FLT3-ITD AML patients: the PONALLO trial